Jaime R Merchan Selected Research

Thrombocytopenia (Thrombopenia)

8/2013	Pazopanib versus sunitinib in metastatic renal-cell carcinoma.
5/2012	A retrospective study of neoadjuvant FOLFIRINOX in unresectable or borderline-resectable locally advanced pancreatic adenocarcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jaime R Merchan Research Topics

Disease

19	Neoplasms (Cancer) 01/2021 - 03/2003
6	Renal Cell Carcinoma (Grawitz Tumor) 10/2021 - 06/2006
5	Pancreatic Neoplasms (Pancreatic Cancer) 02/2018 - 05/2012
4	Hypoxia (Hypoxemia) 10/2021 - 05/2013
4	Neoplasm Metastasis (Metastasis) 01/2015 - 11/2005
3	Adenocarcinoma 02/2018 - 05/2012
3	Breast Neoplasms (Breast Cancer) 01/2015 - 06/2006
2	Carcinoma (Carcinomatosis) 01/2022 - 10/2012
2	Carcinogenesis 01/2021 - 03/2013
2	Diarrhea 01/2021 - 05/2012
2	Measles 10/2017 - 01/2015
2	Thrombocytopenia (Thrombopenia) 08/2013 - 05/2012
2	Fatigue 08/2013 - 05/2012
2	Neutropenia 05/2012 - 06/2006
1	Hypertension (High Blood Pressure) 01/2021
1	Disease Progression 01/2021
1	Alveolar Soft Part Sarcoma 01/2019
1	Sarcoma (Soft Tissue Sarcoma) 01/2019
1	Hypersensitivity (Allergy) 02/2016
1	Colorectal Neoplasms (Colorectal Cancer) 01/2016
1	Vesicular Stomatitis 11/2014
1	Stomach Neoplasms (Stomach Cancer) 01/2014
1	Clear-cell metastatic renal cell carcinoma 08/2013
1	Hand-Foot Syndrome 08/2013
1	Starvation 05/2013
1	Lung Neoplasms (Lung Cancer) 03/2013
1	Fever (Fevers) 05/2012
1	Retinoblastoma (Glioblastoma, Retinal) 10/2010
1	Anemia 06/2006
1	Necrosis 11/2005
1	Thrombosis (Thrombus) 11/2005

Drug/Important Bio-Agent (IBA)

5	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 10/2017 - 06/2006
4	Sunitinib (Sutent)FDA Link 01/2021 - 06/2006
4	Gemcitabine FDA Link 02/2018 - 05/2012
2	Biomarkers (Surrogate Marker)IBA 10/2021 - 01/2021
2	belzutifanIBA 10/2021 - 01/2021
2	pembrolizumabIBA 01/2021 - 01/2019
2	Lipase (Acid Lipase)FDA Link 01/2021 - 06/2006
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019 - 10/2012
2	Tyrosine Kinase InhibitorsIBA 01/2019 - 03/2015
2	130-nm albumin-bound paclitaxelIBA 02/2018 - 04/2013
2	Deoxyglucose (2 Deoxy D glucose)IBA 02/2016 - 05/2013
2	Glucose (Dextrose)FDA LinkGeneric 02/2016 - 05/2013
2	folfirinoxIBA 11/2015 - 05/2012
2	Biological ProductsIBA 01/2015 - 01/2005
2	Urokinase Plasminogen Activator ReceptorsIBA 01/2015 - 02/2009
2	InterferonsIBA 11/2014 - 08/2013
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 10/2012 - 05/2012
2	Peptide Hydrolases (Proteases)FDA Link 10/2012 - 06/2006
2	Plasminogen Activators (Plasminogen Activator)IBA 10/2012 - 06/2006
1	PlatinumIBA 01/2022
1	enfortumab vedotinIBA 01/2022
1	Transcription Factors (Transcription Factor)IBA 01/2021
1	lenvatinibIBA 01/2021
1	Everolimus FDA Link 01/2021
1	Therapeutic UsesIBA 12/2020
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2019
1	Immune Checkpoint InhibitorsIBA 01/2019
1	Axitinib (AG 013736)IBA 01/2019
1	Albumin-Bound Paclitaxel FDA Link 02/2018
1	Pharmaceutical PreparationsIBA 02/2016
1	ixabepilone (BMS 247550)FDA Link 01/2016
1	Bevacizumab (Avastin)FDA Link 03/2015
1	temsirolimus FDA Link 03/2015
1	LuciferasesIBA 01/2015
1	AnthracyclinesIBA 01/2014
1	Epidermal Growth Factor (EGF)IBA 01/2014
1	Trastuzumab (Herceptin)FDA Link 01/2014
1	Alanine Transaminase (SGPT)IBA 08/2013
1	pazopanib FDA Link 08/2013
1	Proteins (Proteins, Gene)FDA Link 04/2013
1	Cysteine (L-Cysteine)FDA Link 04/2013
1	AcidsIBA 04/2013
1	Histone Deacetylases (Histone Deacetylase)IBA 03/2013
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 03/2013
1	Dinoprostone (PGE2)FDA Link 03/2013
1	CytokinesIBA 03/2013
1	EnzymesIBA 03/2013
1	15-hydroxyprostaglandin dehydrogenaseIBA 03/2013
1	Metalloproteases (Metalloproteinases)IBA 10/2012
1	Plasminogen Activator Inhibitor 1IBA 10/2012
1	IntegrinsIBA 10/2012
1	Cetuximab (Erbitux)FDA Link 10/2012
1	Leucovorin (Folinic Acid)FDA Link 05/2012
1	Fluorouracil (Carac)FDA LinkGeneric 05/2012
1	Irinotecan (Camptosar)FDA LinkGeneric 05/2012
1	beta Subunit Luteinizing HormoneIBA 10/2010
1	matrigelIBA 10/2010
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 06/2006
1	cyclo(Arg-Pro) (CI 4)IBA 06/2006
1	AntibodiesIBA 06/2006
1	Antineoplastic Agents (Antineoplastics)IBA 06/2006
1	Tissue Plasminogen Activator (Alteplase)FDA Link 06/2006

Therapy/Procedure

8	Therapeutics 01/2021 - 06/2005
2	Drug Therapy (Chemotherapy) 01/2014 - 05/2012
1	Oncolytic Virotherapy 01/2015
1	Intravenous Administration 01/2015
1	Stents 05/2012
1	Neoadjuvant Therapy 05/2012
1	Nephrectomy 11/2005